BioPharma Dive1d
Enhertu, with new OK, set to supplant chemo in HER2-low breast cancer
The clearance is a step forward in AstraZeneca and Daiichi Sankyo’s plan to position antibody-drug conjugates like Enhertu ...
Cancer breakthrough as new jab to 'stop disease before you get it'
A new cancer vaccine that ‘stops disease before you get it’ is being created by pharmaceutical giant GSK and the University ...
My parents weren't proud of me - and my own BROTHER didn't trust me: Spencer Matthews admits he was a 'slave to the bottle' - and reveals what wife Vogue really …
Call it obsession, addiction, passion, sheer lunacy, whatever - the former star of Made in Chelsea Spencer Matthews has it, ...
Memphis basketball routs UAB as Dain Dainja makes emphatic return to starting lineup
The thunderous dunk by Memphis basketball's Dain Dainja over UAB star Yaxel Lendeborg in the opening minutes Sunday at ...
Memphis basketball vs UAB score today: Live updates, channel, PJ Haggerty, Tyrese Hunter
It’s Memphis vs UAB in AAC play this college basketball season. Follow for live score updates, game highlights from ...
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...
India’s Torrent Pharma misses Q3 profit estimates, hurt by insulin plant closure
(Reuters) - India's Torrent Pharmaceuticals reported a smaller-than-expected third-quarter profit on Friday, hurt by the ...
bovnews6d
Jefferies Just Upgraded Crinetics Pharmaceuticals Inc (CRNX) Stock—What Does This Mean for Investors?
Jefferies has recently raised Crinetics Pharmaceuticals Inc (CRNX) stock to Buy rating, as announced on January 22, 2025, according to Finviz. Earlier, on March 6, 2024, Citigroup had initiated the ...
India's Mankind Pharma misses Q3 profit view as expenses jump
India's Mankind Pharma reported a smaller-than-expected third-quarter profit on Thursday, hurt by a sharp rise in expenses.